89 related articles for article (PubMed ID: 6792754)
1. beta-Lactamase activity in slow-growing nonpigmented mycobacteria and their sensitivity to certain beta-lactam antibiotics.
Kasik JE; Monick M; Schwarz B
Tubercle; 1980 Dec; 61(4):213-9. PubMed ID: 6792754
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
Flores AR; Parsons LM; Pavelka MS
Microbiology (Reading); 2005 Feb; 151(Pt 2):521-532. PubMed ID: 15699201
[TBL] [Abstract][Full Text] [Related]
3. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
[TBL] [Abstract][Full Text] [Related]
4. Relationship between beta-lactamase activity and resistance to beta-lactam antibiotics in Mycobacterium smegmatis.
Yabu K; Kaneda S; Ochiai T
Microbiol Immunol; 1985; 29(9):803-9. PubMed ID: 3877858
[TBL] [Abstract][Full Text] [Related]
5. Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.
Jarlier V; Gutmann L; Nikaido H
Antimicrob Agents Chemother; 1991 Sep; 35(9):1937-9. PubMed ID: 1952873
[TBL] [Abstract][Full Text] [Related]
6. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
Kwon HH; Tomioka H; Saito H
Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
[TBL] [Abstract][Full Text] [Related]
7. beta-Lactamase activity in human pus.
Bryant RE; Rashad AL; Mazza JA; Hammond D
J Infect Dis; 1980 Oct; 142(4):594-601. PubMed ID: 6969281
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactam antibiotics and mycobacteria.
Finch R
J Antimicrob Chemother; 1986 Jul; 18(1):6-8. PubMed ID: 3093446
[No Abstract] [Full Text] [Related]
9. Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.
Quinting B; Reyrat JM; Monnaie D; Amicosante G; Pelicic V; Gicquel B; Frère JM; Galleni M
FEBS Lett; 1997 Apr; 406(3):275-8. PubMed ID: 9136901
[TBL] [Abstract][Full Text] [Related]
10. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.
Brook I; Yokum P
Chemotherapy; 1983; 29(1):18-23. PubMed ID: 6339177
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica.
Jimenez-Valera M; Ruiz-Bravo A; Ramos-Cormenzana A
Antimicrob Agents Chemother; 1986 Jan; 29(1):104-6. PubMed ID: 3488014
[TBL] [Abstract][Full Text] [Related]
12. Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
Dubée V; Soroka D; Cortes M; Lefebvre AL; Gutmann L; Hugonnet JE; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2015 May; 59(5):2938-41. PubMed ID: 25733512
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the growth of six potentially-pathogenic mycobacteria by beta-lactam/beta-lactamase-inhibitors.
Prabhakaran K; Harris EB; Randhawa B
Microbios; 1997; 91(366):7-14. PubMed ID: 9467917
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of mycobacterial resistance to penicillins and cephalosporins.
Mishra RK; Kasik JE
Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):73-7. PubMed ID: 4985843
[No Abstract] [Full Text] [Related]
15. Beta-lactamase activity in mycobacteria other than M. tuberculosis.
Coira A; Salvadó M; Reig R; Chaves J; Segura C
J Chemother; 1995 Apr; 7(2):106-8. PubMed ID: 7666114
[TBL] [Abstract][Full Text] [Related]
16. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Dinçer I; Ergin A; Kocagöz T
Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
[TBL] [Abstract][Full Text] [Related]
17. [A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Nakagawa Y; Shimazu K; Ebihara M; Aman K
Kekkaku; 1999 May; 74(5):447-52. PubMed ID: 10386034
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
Cohen KA; El-Hay T; Wyres KL; Weissbrod O; Munsamy V; Yanover C; Aharonov R; Shaham O; Conway TC; Goldschmidt Y; Bishai WR; Pym AS
EBioMedicine; 2016 Jul; 9():170-179. PubMed ID: 27333036
[TBL] [Abstract][Full Text] [Related]
19. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
[TBL] [Abstract][Full Text] [Related]
20. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
Wallace RJ; Nash DR; Johnson WK; Steele LC; Steingrube VA
J Infect Dis; 1987 Dec; 156(6):959-66. PubMed ID: 3500241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
